Human mAChR antibodies from Sjögren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level

Clinical Immunology

Volumn 113, Issue 2, 2004, Pages 193-202

  Reina, Silvia ^a   Sterin Borda, Leonor ^a   Orman, Betina ^a   Borda, Enri ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autoantibodies in SS; Cerebral frontal cortex; eNOS mRNA; mAChR; nNOS mRNA; NOS activity

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN G; MESSENGER RNA; MUSCARINIC RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; RECEPTOR ANTIBODY;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIOASSAY; RAT; SJOEGREN SYNDROME;

ADULT; ANIMALS; AUTOANTIBODIES; CELLS, CULTURED; CEREBRAL CORTEX; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; ISOENZYMES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; RNA, MESSENGER; SJOGREN'S SYNDROME;

EID: 4644250400     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.08.005     Document Type: Article

References (51)

1. A. Binder, P.J. Maddinson, P. Skinner, A. Kurtz, and D.A. Isenbserg Sjögren syndrome: association with type 1 diabetes mellitus Br. J. Rheumatol. 28 1989 518 521
2. V. Strand, and N. Talal Advances in the diagnosis and concept of Sjögren syndrome (autoimmune exocrinopathy) Bull. Rheum. Dis. 92 1980 212 226
3. P.C. Fox, J. Törnwall, T. Maruyama, and M. Stern Evolving concept of diagnosis, pathogenesis and therapy of Sjögren syndrome Curr. Opin. Rheumatol. 10 1998 446 456
4. 3 muscarinic receptors in primary Sjögren's syndrome Clin. Exp. Immunol. 104 1996 454 459
5. 3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome Invest. Ophthalmol. Visual. Sci. 39 1998 151 156
6. S. Bacman, A. Berra, L. Sterin-Borda, and E. Borda Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome Investig. Ophthalmol. Vis. Sci. 42 2001 321 327
7. C. Perez Leiros, L. Sterin-Borda, O. Hubscher, R. Arana, and E. Borda Activation of nitric oxide signalling through muscarinic receptors in submandibular glands by primary Sjögren syndrome antibodies Clin. Immunol. 90 1999 190 195
8. H. Yamamoto, N.E. Sims, S.P. Maxney, K.H. Nguyen, Y. Nakagawa, and M.G. Humphreys-Beher Alterations in the secretory response of nonobese diabetic (NOD) mice to muscarinic receptor stimulation Clin. Immunol. Immunopathol. 78 1996 245 255
9. A. Berra, L. Sterin-Borda, S. Bacman, and E. Borda Role of salivary IgA in the pathogenesis of Sjögren syndrome Clin. Immunol. 104 2002 49 57
10. M.G. Humphreys-Beher, J. Brayer, S. Yamachika, A.B. Peck, and R. Jonsson An alternative perspective to the immune response in autoimune exocrinopathy: induction of functional quiescence rather than destructive autoaggression Scand. J. Immunol. 49 1999 7 10
11. C. Perez Leiros, L. Sterin-Borda, E. Borda, J.C. Goin, and M.M. Hosey Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease J. Biol. Chem. 272 1997 12989 12993
12. W.P. Hausdorff, M.G. Caron, and R.J. Lefkowitz Turning off the signal: desensitization of beta adrenergic function FASEB J. 4 1990 2881 2889
13. L. Kovacs, T. Torok, and F. Bari Impaired microvascular response to cholinergic stimuli in primary Sjögren syndrome Ann. Rheum. Dis. 59 2000 48 53
14. R.I. Fox, M. Stern, and P. Michelson Update in Sjögren syndrome Curr. Opin. Rheumatol. 12 2000 391 398
15. J.H. Stone, and H.W. Francis Immune-mediated inner ear disease Curr. Opin. Rheumatol. 12 2000 32 40
16. P.B. Billings, E.M. Keithley, and J.P. Harris Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70 Ann. Otol., Rhinol., Laryngol. 104 1995 181 188
17. M. Martinez Lavin, and A.G. Hermosillo Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia Semin. Arthritis Rheum. 29 2000 197 199
18. H. Calkins, and P.C. Rowe Relationship between chronic fatigue syndrome and neurally mediated hypotension Cardiol. Rev. 6 1998 125 134
19. E. Borda, C. Perez Leiros, S. Bacman, A. Berra, and L. Sterin-Borda Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation Int. J. Cardiol. 70 1999 23 32
20. C. Lafitte Neurological manifestations in Sjögren syndrome Arch. Neurol. 57 2000 411 413
21. S.T. Valtysdottir, B. Gudbjornsson, and U. Lindqvist Anxiety and depression in patients with primary Sjögren syndrome J. Rheumatol. 27 2000 165 169
22. J. Grafman K.J. Holyak F. Boller Structure and functions of the human prefrontal cortex Annals of the New York vol. 769 1995 Academy of Science New York 420 486
23. C. Colombo, M. Abbruzzese, S. Livian, G. Scotti, M. Locatelli, A. Bonfanti, and S. Scarone Memory functions and temporal-limbic morphology in schizophrenia Psychiatry Res. Neuroimagining 50 1993 45 56
24. J.S. Yeomans Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia Neuropsychopharmacology 12 1995 3 16
25. C. Albrecht, H. Von der Kammer, M. Mayhus, J. Klaudiny, M. Schweizer, and R.M. Nitsch Muscarinic acetylcholine receptors induce the expression of the immediate early growth gene CYR61 J. Biol. Chem. 275 2000 28929 28936
26. P.M. Wall, and C. Messier Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory Psychopharmacology 160 2002 233 244
27. L. Sterin-Borda, S. Ganzinelli, A. Berra, and E. Borda Novel insight into the mechanisms involved in the regulation of the m1 muscarinic receptor, iNOS and nNOS mRNA levels Neuropharmacology 45 2003 260 269
28. T. Gudi, G.K.P. Hong, A.B. Vaandrager, S.M. Lohmann, and R.B. Pilz Nitric oxide and cGMP regulate gene expression in neuronal and glial cells by acting type II cGMP-dependent protein kinase FASEB J. 13 1999 2143 2152
29. M.A. Wong, V. Rettori, A. Al-Shekhlee, P.B. Bongiorno, G. Canteros, S.M. McCann, P.W. Gold, and J. Licino Inducible nitric oxide synthase gene expression in the brain during systemic inflammation Nat. Med. 2 1996 581 584
30. G.T. Liberatore, V. Jackson-Lewism, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat. Med. 5 1999 1403 1409
31. C. Vitali, and S. Bombarderi The European classification criteria for Sjögren syndrome: proposal for modification of the rules for classification suggested by the analysis of the receiver operating characteristic curve of the criteria performance J. Rheum. 24 1997 S11 S12 (Suppl)
32. T. Borda, A.M. Genaro, L. Sterin-Borda, and G. Cremaschi Involvement of endogenous nitric oxide signaling system in brain muscarinic acetylcholine receptor activation J. Neural Transm. 105 1998 193 204
33. T. Borda, R. Perez Rivera, L. Joensen, R. Gomez, and L. Sterin-Borda Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction J. Immunol. 168 2002 3667 3674
34. P. Chomozynski, and N. Saachi Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction Ann. Biochem. 162 1987 156 159
35. M.J. Berridge, and R.F. Irvine Inositol phosphates and cell signaling Nature 341 1989 197 205
36. R.G. Smallridge, J.G. Kiang, I.D. Gist, H.G. Feim, and R.J. Galloway U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells Endocrinology 131 1992 1883 1888
37. O. Scharff, and B. Foder Effect of trifluoroperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte calcium ATPase Biochem. Biophys. Acta 772 1984 29 36
38. A. Mulsh, and R. Busse NG-nitro-l-argentine impairs nitric oxide synthase from l-argentine Naunyn-Schmiedeberg's Arch. Pharmacol. 347 1990 143 147
39. D.D. Rees, R.M. Palmer, R. Schulz, H.F. Hodson, and S. Moncada Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo Br. J. Pharmacol. 101 1990 746 752
40. H.Q. Zhang, W. Fast, M.A. Marletta, P. Martasek, and R.B. Silverman Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-l-arginine J. Med. Chem. 40 1997 3869 3870
41. D.D. Belsham, W.C. Wetsel, and P.L. Mellon NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expression EMBO J. 15 1996 538 547
42. M. Eigenthaler, S.M. Lohmann, U. Walter, and R.B. Pilz Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression Rev. Physiol., Biochem. Pharmacol. 135 1998 174 209
43. H.M. Johnston, and B.J. Morris NMDA and nitric oxide regulate the expression of calcium/calmodulin-dependent kinase II in the hippocampal dentate gyrus Mol. Brain Res. 31 1995 141 150
44. N. Peunova, and G. Enikolopov Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells Nature (London) 364 1993 450 453
45. B.J. Morris Stimulation of immediate early gene expression in striatal neurons by nitric oxide J. Biol. Chem. 270 1995 24740 24744
46. H. Von der Kammer, C. Demiralay, B. Andersen, C. Albrecht, M. Mayhaus, and R.M. Nitsch Regulation of gene expression by muscarinic acetylcholine receptors Biochem. Soc. Symp. 67 2001 131 140
47. J. Garthwaite Potent and selective inhibition of nitric oxide sensitive guanylyl cyclase by 1H-[1,2,4,]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) Mol. Pharmacol. 48 1995 184 188
48. M. Colasanti, and H. Suzuki The dual personality of nitric oxide Trends Pharmacol. 21 2000 249 252
49. S. Przedborski, M. Vila, V. Jackson-Lewis, and T.M. Dawson Reply: a new look at the pathogenesis of Parkinson's disease Trends Pharmacol. 21 2000 165 166
50. D. Bishop-Bailey, S.W. Larkin, T.D. Warner, G. Chen, and J.A. Mitchell Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture Br. J. Pharmacol. 121 1997 125 133
51. W.M. Qi, Z.Q. Yan, P.G. Whang, Z. Qi, L.E. Chen, A.V. Seaber, J.S. Stamler, and J.R. Urbaniak Gene and protein expressions of nitric oxide synthases in ischemia-reperfused peripheral nerve of the rat Am. J. Physiol. 281 2001 F849 F856